Pathways Health Ultra Omega-3 500 EPA/250 DHA softgels
Pathways Health Ultra Omega-3 500 EPA/250 DHA softgels, NPN 80064439: natural health product licensed in Canada. Medicinal ingredients: Huile de poisson.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Engraulidae - en entier Potency : 500 milligramme eicosapentaenoic acid | 1,000 milligramme | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 250 milligramme docosahexaenoic acid | Not specified | Not calculated |
Non-medicinal ingredients
Glycérine, Citrate de triéthyle, Vitamine E, Gélatine, Eau purifiée, Copolymère d'acide méthacrylique et d'acrylate d'éthyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 9 years ; maximum: 17 years | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to maintain cardiovascular health and cognitive function. Helps to reduce serum triglycerides/ triaglycerols. Helps support the development of thge brain, eyes and nerves in children 18 years and younger
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No warning text available in the imported data.
Product record
- Licence holder
- Pathways Health Inc.
- NPN or DIN-HM
- 80064439
- Status
- Active licence
- Licence date
- 5 October 2015
- Revision date
- 22 July 2016
- Form
- Gélule entéro-soluble
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80064439
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Huile de poisson
Read the warning, when it applies and the studies cited
FISH OIL
Route of administration: Oral
Cautions and warnings
Condition of application: Pain of rheumatoid arthritis.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Condition of application: Healthy mood balance.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Pathways Health Ultra Omega-3 500 EPA/250 DHA softgels: composition and ingredients”, https://compoatlas.com/en/supplements/canada/80064439-pathways-health-ultra-omega-3-500-epa-250-dha-softgels, updated 22 July 2016.